EUVIMEDEUVIMED entdecken
Crossref

Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?

Rintaro Nagayama iD, Toshiharu Ueki iD, Yasuhiro Shimizu iD, Susumu Hijioka iD, Masafumi Nakamura iD, Masayuki Kitano iD, Kazuo Hara iD, Atsushi Masamune iD, Toshifumi Kin iD, Keiji Hanada iD, Shinsuke Koshita iD, Reiko Yamada iD und 12 weitere

Journal of Hepato-Biliary-Pancreatic Sciences · 2024

DOI: 10.1002/jhbp.1394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Rintaro Nagayama und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We compared the results of preoperative pancreatic juice cytology (PJC) and final pathological diagnosis after resection in patients who underwent resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas to determine whether preoperative PJC can help determine therapeutic strategies.

Methods

Of 1130 patients who underwent surgical resection IPMN at 11 Japanese tertiary institutions, the study included 852 patients who underwent preoperative PJC guided by endoscopic retrograde cholangiopancreatography (ERCP).

Results

The accuracy of preoperative PJC for differentiation between cancerous and noncancerous lesions were 55% for IPMN overall; 59% for the branch duct type; 49% for the main pancreatic duct type; 53% for the mixed type, respectively. On classifying IPMN according to the diameters of the mural nodule (MN) and main pancreatic duct (MPD), the corresponding values for diagnostic performance were 40% for type 1 (MN ≥5 mm and MPD ≥ 10 mm); 46% for type 2 (MN ≥5 mm and MPD < 10 mm); 61% for type 3 (MN < 5 mm and MPD ≥ 10 mm); 72% for type 4 (MN < 5 mm and MPD < 10 mm), respectively.

Conclusions

PJC in IPMN is not a recommended examination because of its low overall sensitivity and no significant difference in diagnostic performance by type, location, or subclassification. Although the sensitivity is low, the positive predictive value is high, so we suggest that pancreatic juice cytology be performed only in cases where the patient is not sure about surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic Intraductal NeoplasmsPancreatic NeoplasmsHumansPancreatic JuicePancreatic DuctsRetrospective Studies

Stichwörter der Autor:innen

endoscopic retrograde cholangiopancreatographyintraductal papillary mucinous neoplasmspancreatic carcinomapancreatic juice cytologypancreatic neoplasms

Autor:innen und Institutionen

  • Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
  • Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.
  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center, Tokyo, Japan.
  • Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Second Department of Internal Medicine, Wakayama Medical University School of Medicine, Wakayama, Japan.
  • Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan.

ORCID-Profile: Rintaro Nagayama, Toshiharu Ueki, Yasuhiro Shimizu, Susumu Hijioka, Masafumi Nakamura, Masayuki Kitano, Kazuo Hara, Atsushi Masamune, Toshifumi Kin, Keiji Hanada, Shinsuke Koshita, Reiko Yamada, Mamoru Takenaka, Takao Itoi, Akio Yanagisawa, Takao Otuka, Seiko Hirono, Atsushi Kanno, Noboru Ideno, Takamichi Kuwahara, Akinori Shimizu, Ken Kamata, Yasutsugu Asai, Yoshifumi Takeyama

Zitieren

APA

Nagayama, R., Ueki, T., Shimizu, Y., Hijioka, S., Nakamura, M., Kitano, M., Hara, K., Masamune, A., Kin, T., Hanada, K., Koshita, S., Yamada, R., Takenaka, M., Itoi, T., Yanagisawa, A., Otuka, T., Hirono, S., Kanno, A., Ideno, N., …, & Takeyama, Y. (2024). Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1394

Vancouver

Nagayama R, Ueki T, Shimizu Y, Hijioka S, Nakamura M, Kitano M, et al. Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.1394

BibTeX
@article{Nagayama2024,
  author = {Nagayama, Rintaro and Ueki, Toshiharu and Shimizu, Yasuhiro and Hijioka, Susumu and Nakamura, Masafumi and Kitano, Masayuki and Hara, Kazuo and Masamune, Atsushi and Kin, Toshifumi and Hanada, Keiji and Koshita, Shinsuke and Yamada, Reiko and Takenaka, Mamoru and Itoi, Takao and Yanagisawa, Akio and Otuka, Takao and Hirono, Seiko and Kanno, Atsushi and Ideno, Noboru and Kuwahara, Takamichi and Shimizu, Akinori and Kamata, Ken and Asai, Yasutsugu and Takeyama, Yoshifumi},
  title = {Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas?},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2024},
  doi = {10.1002/jhbp.1394}
}
Kostenlos starten →